Further Information
SAMSN1, HACS1, SAM domain, SH3 domain and nuclear localisation signals, 1, SH3-SAM adaptor protein, hematopoietic adaptor containing SH3 and SAM domains 1, NASH1, SASH2, SH3D6B, SAM domain, SH3 domain and nuclear localization signals 1, SAM and SH3 domain containing 2, SAM domain, SH3 domain and nuclear localization signals, 1, nuclear localization signals, SAM and SH3 domain containing 1
Peptide ELISA: antibody detection limit dilution 1:64000.Western Blot:Approx 48kDa band observed in Jurkat Tcell lysate (calculated MW of 41.7kDa according to NP_071419.2). The observed size is consistent with observations with competing products. Recommended concentration: 0.5-1.5ug/ml
- Zhu YX, Benn S, Li ZH, Wei E, Masih-Khan E, Trieu Y, Bali M, McGlade CJ, Claudio JO, Stewart AK. The SH3-SAM Adaptor HACS1 is Up-regulated in B Cell Activation Signaling Cascades. J Exp Med. 2004 Sep 20;200(6):737-47.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: IRLDTLSASLGRSC
64092
SAM domain, SH3 domain and nuclear localization signals 1
SAMSN1
Homo sapiens
Liquid
NP_071419.2
21361922
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer
Please note that the immunogen sequence is present in NP_071419.2 (and in AAK07746) but is no longer present in the latest reference sequence (NP_071419.3 at 05/10/05). This latest version has not been subject to final review by NCBI. This antibody may be recognising one particular isoform.
Q9NSI8